Evidence map›Paper›PMID 28719292›Full record

ArticleThe American journal of tropical medicine and hygiene2017

Malaria Infection and Gametocyte Carriage Rates in Preparation for Transmission Blocking Vaccine Trials in Bancoumana, Mali.

Mahamadoun Hamady Assadou, Issaka Sagara, Sara A Healy, Merepen Agnes Guindo, Mamady Kone, Sintry Sanogo, M'Bouye Doucoure, Sekouba Keita, Ruth D Ellis, Yimin Wu and 3 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. The Prevalence of HumanTropical medicine and infectious disease · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Mahamadoun Hamady AssadouMalaria Research and Training Center, FMOS-FAPH, Mali-NIAID-ICER, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Issaka SagaraMalaria Research and Training Center, FMOS-FAPH, Mali-NIAID-ICER, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Sara A HealyLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.
Merepen Agnes GuindoMalaria Research and Training Center, FMOS-FAPH, Mali-NIAID-ICER, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Mamady KoneMalaria Research and Training Center, FMOS-FAPH, Mali-NIAID-ICER, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Sintry SanogoMalaria Research and Training Center, FMOS-FAPH, Mali-NIAID-ICER, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
M'Bouye DoucoureMalaria Research and Training Center, FMOS-FAPH, Mali-NIAID-ICER, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Sekouba KeitaMalaria Research and Training Center, FMOS-FAPH, Mali-NIAID-ICER, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Ruth D EllisBiologics Consulting Group Inc., Alexandria, Virginia.
Yimin WuPATH-Malaria Vaccine Initiative, Washington, District of Columbia.
Freda OmaswaUniversity of British Columbia, Vancouver, Canada.
Patrick E DuffyLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland.
Ogobara K DoumboMalaria Research and Training Center, FMOS-FAPH, Mali-NIAID-ICER, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Université des Sciences, des Techniques et des Technologies de Bamako · MLNational Institute of Allergy and Infectious Diseases · USUniversity of British Columbia · CAU.S. President's Malaria Initiative · US

Funding

Vaccines to Interrupt Malaria Transmission: Clinical DevelopmentZIAAI001009 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DUFFY, PATRICK · 2009 to 2025
$84.8M
Mali International Center for Excellence in Research: Malaria Clinical ResearchZIAAI001056 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DUFFY, PATRICK · 2009 to 2024
$43.1M
Vaccines to Interrupt Malaria Transmission: Discovery and AssaysZIAAI001007 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DUFFY, PATRICK · 2009 to 2025
$28.9M
Malaria Vaccines: Pvs230D1-EPA and PvCSPZIAAI001224 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DUFFY, PATRICK · 2017 to 2024
$596k
6 · The paper itself

Abstract

The epidemiological characterization of transmission reservoirs is a critical step in preparation for interventional trials for malaria elimination/eradication. Using cluster sampling and households/compounds as units of sampling, we recruited and followed monthly, from June 2011 to June 2012, 250 volunteers 3 months to 50 years of age in Bancoumana, Mali. In July 2012, only participants 5-35 years of age (

Indexed as

AdolescentAdultChildChild, PreschoolClinical Trials as TopicFemaleHumansInfantMalaria, FalciparumMalaria VaccinesMaleMaliMiddle AgedYoung AdultMalaria Vaccines

Identifiers

PMID28719292
PMCPMC5508881
OpenAlexW2617675808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.